StocksRunner logo
mail
search
 
menu
 
BioAtla
1.95
-3.23%
 
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
 
 

BCAB

 

BioAtla

$1.95

 
-$0.06 | -3.23%
 

Stock Viewers 1159

 
 
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
Open
$ 2.00
 
 
MKT CAP
$ 94.01M
 
High
$ 2.07
 
 
VOL
$ 690.29K
 
Low
$ 1.94
 
 
AVG VOL
$ 1.46M
 
 
 

BCAB Stock Rating Review

 
BioAtla (BCAB) has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

BCAB Total Score

 
 
 

Chart

 
 

1.85

1.71

1.5

1.29

 
 
1month
3month
6month
1year
 
Total Return
BCAB
vs.
S&P500
 

 
1-week Return
-1.02%
 
+0.52%
 
 
5-week Return
+8.94%
 
+4.62%
 
 
10-week Return
+35.42%
 
+10.89%
 
 
 

BCAB Risk Level

 

This Indicator assigning BCAB risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
BCAB Risk Level
LOW
HIGH

Risk Volatility

 

BCAB has Extreme Risk Level

Click here to check what is your level of risk

 

BCAB Analysts Opinion

 

BCAB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 
 

Activity

×
 

Activity

 
 

Future

×
 

Future

 
 
 

BCAB Analysts Opinion

BCAB Analysts opinion is negative and it remained unchanged from the past 3 months

 

BCAB Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
67%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
NA
NA
 

BCAB Street Opinion 

BCAB Street view is bullish and have negative views on the near-term outlook

 

BCAB Performance Sentiment

 
Sentiments overview associated with BCAB events and the stock performance.
 
67%
0%
Positive
Negative
2 out of 3
events present
0 out of 3
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

BCAB Earnings

 

The TTM reflects 12-month period, providing review of BCAB financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
-
 
 
Operating Exp
110
130
108
+0.92%
 
 
Operating Inc
-110
-130
-108
-
 
 
Net Interest Inc
5
6
2
+58.11%
 
 
Interest Exp
-
-
-
 
 
Interest Inc
5
6
2
+58.11%
 
 
Other Inc Exp
-
-
 
 
EPS Growth
-
 
 

BCAB Financial Health

 

The company financial health has moderately improved over the past year, reflecting average market demand and somewhat effective business strategies. There have been noticeable gains in profitability and cost management, but there is still substantial room for growth and optimization.

 

Financial Score

 
2.65
 
Next Earnings Date: Nov 05, 2024
 
 
Headlines
Last Modify
Price
% Change

 
Investors Activity
1 Week Ago
2.20
-6.38%
 
New Product
3 Weeks Ago
1.66
-3.49%
 
 
BCAB Latest Updates +
 
 
 
StocksRunner

Explore our BCAB Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored BCAB Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our BCAB Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
Top Banner
 
StocksRunner
  Overview  
  
StocksRunner
  Analysis  
  
StocksRunner
   Risks   
  
StocksRunner
  Rating  
  
StocksRunner
  Chart  
  
StocksRunner
  Analysts  
  
StocksRunner
  Street  
  
StocksRunner
  Sentiment  
  
StocksRunner
  Earnings  
  
StocksRunner
  Headlines  
 
 
 
 

Stock Insights

 
 
 

Not Enough Information

 
 
 

BCAB Risk Level

 
 
 

The Indicator assigning BCAB risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
BCAB Risk Level
LOW
HIGH

Risk Volatility

 

BCAB has Extreme Risk Level. Click here to check what is your level of risk

 
 
 
 
 

BCAB

 

BioAtla

$1.95

 
-$0.06 | -3.23%
 

Stock Viewers 1159

 
 

 
Open
$ 2.00
 
 
MKT CAP
$ 94.01M
 
High
$ 2.07
 
 
VOL
$ 690.29K
 
Low
$ 1.94
 
 
AVG VOL
$ 1.46M
 
 
 

BCAB Stock Rating

 
BioAtla (BCAB) has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

Chart

 
 

1.85

1.71

1.5

1.29

 
 
1month
3month
6month
1year
 
Total Return
BCAB
vs.
S&P500
 

 
1-week Return
-1.02%
 
+0.52%
 
 
5-week Return
+8.94%
 
+4.62%
 
 
10-week Return
+35.42%
 
+10.89%
 
 
 

BCAB Analysts Opinion

 

BCAB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 
 

Activity

×
 

Activity

 
 

Future

×
 

Future

 
 
 

BCAB Analysts Opinion

BCAB Analysts opinion is negative and it remained unchanged from the past 3 months

 

BCAB Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
67%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
NA
NA
 

BCAB Street Opinion 

BCAB Street view is bullish and have negative views on the near-term outlook

 
BCAB Performance Sentiment
 
Sentiments overview associated with BCAB events and the stock performance.
 
67%
0%
Positive
Negative
2 out of 3
events present
0 out of 3
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

BCAB Earnings

 

The TTM data reflects the most recent 12-month period, providing overview of BCAB financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
-
 
 
Operating Exp
110
130
108
+0.92%
 
 
Operating Inc
-110
-130
-108
-
 
 
Net Interest Inc
5
6
2
+58.11%
 
 
Interest Exp
-
-
-
 
 
Interest Inc
5
6
2
+58.11%
 
 
Other Inc Exp
-
-
 
 
EPS Growth
-
 
 

BCAB Financial Health

 

The company financial health has moderately improved over the past year, reflecting average market demand and somewhat effective business strategies. There have been noticeable gains in profitability and cost management, but there is still substantial room for growth and optimization.

 

Financial Score

 
2.65
 
Next Earnings Date: Nov 05, 2024
 
Headlines
Last Modify
Price
% Change

 
Investors Activity
1 Week Ago
2.20
-6.38%
 
New Product
3 Weeks Ago
1.66
-3.49%
 
 
BCAB Latest Updates +
 
 
 
 
 

Total Score

 
 
 
 

BCAB Total Score

 
 
 
 
 
 
 
StocksRunner

Discover BCAB Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of BCAB. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our BCAB Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BCAB Stock trends

BCAB Stock performance

BCAB Stock analysis

BCAB investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker